User contributions
From WikiPathways
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
- 13:03, 21 February 2024 Bos taurus:SIDS susceptibility pathways (Update disease node) (top)
- 12:59, 21 February 2024 Mus musculus:Focal adhesion: PI3K-Akt-mTOR signaling pathway (Upgrade disease node, standardize case) (top)
- 12:53, 21 February 2024 Homo sapiens:DNA damage response (Upgrade disease node, standardize case)
- 12:50, 21 February 2024 Homo sapiens:DNA damage response (Standardize case)
- 12:47, 21 February 2024 Bos taurus:DNA damage response (Improve fix for text-encoding issue) (top)
- 12:46, 21 February 2024 Sus scrofa:DNA damage response (Fix typo, remove obsolete field, upgrade disease node, standardize case) (top)
- 12:44, 21 February 2024 Bos taurus:DNA damage response (Fix typo, remove obsolete field, upgrade disease node, standardize case)
- 12:36, 21 February 2024 Homo sapiens:Epithelial to mesenchymal transition in colorectal cancer (Upgrade disease node)
- 04:58, 21 February 2024 Homo sapiens:miRNA role in immune response in sepsis (Upgrade disease node, standardize case) (top)
- 04:54, 21 February 2024 Homo sapiens:Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids (Standardize case)
- 04:53, 21 February 2024 Rattus norvegicus:p53 pathway (Upgrade disease node)
- 04:50, 21 February 2024 Homo sapiens:miRNA regulation of p53 pathway in prostate cancer (Upgrade disease node)
- 04:47, 21 February 2024 Bos taurus:Angiogenesis (Remove obsolete availability field) (top)
- 04:46, 21 February 2024 Bos taurus:Angiogenesis (Upgrade disease node)
- 04:42, 21 February 2024 Homo sapiens:Fumarate hydratase-deficient papillary renal cell carcinoma (Fix truncated pathway labels, upgrade disease nodes, standardize case)
- 03:11, 21 February 2024 Homo sapiens:Photodynamic therapy-induced NF-kB survival signaling (Upgrade metabolite and disease nodes)
- 03:06, 21 February 2024 Sus scrofa:Target of rapamycin (TOR) signaling (Upgrade disease node, standardize case) (top)
- 03:02, 21 February 2024 Homo sapiens:MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors (Ontology Term : 'neoplastic cell' added !)
- 03:01, 21 February 2024 Homo sapiens:MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors (Upgrade disease node, standardize case)
- 02:58, 21 February 2024 Homo sapiens:Osteoarthritic chondrocyte hypertrophy (Upgrade disease node)
- 02:56, 21 February 2024 Mus musculus:Hypoxia-dependent self-renewal of myoblasts (Upgrade disease node, economize layout, standardize case) (top)
- 02:53, 21 February 2024 Mus musculus:Hypoxia-dependent differentiation of myoblasts (Upgrade disease node, economize layout, standardize case) (top)
- 02:51, 21 February 2024 Homo sapiens:Hypoxia-mediated EMT and stemness (Upgrade disease node, economize layout, standardize case)
- 02:49, 21 February 2024 Homo sapiens:FABP4 in ovarian cancer (Upgrade disease node)
- 02:46, 21 February 2024 Homo sapiens:FABP4 in ovarian cancer (Ontology Term : 'neoplastic cell' added !)
- 02:39, 21 February 2024 Homo sapiens:Glial cell differentiation (Upgrade disease node, miRNA node, economize layout, standardize case)
- 02:30, 21 February 2024 Homo sapiens:Glial cell differentiation (Ontology Term : 'neural stem cell' added !)
- 02:20, 21 February 2024 Homo sapiens:One-carbon metabolism (Standardize case)
- 02:17, 21 February 2024 Homo sapiens:Thyroxine (thyroid hormone) production (Standardize font family, refine ordering)
- 02:09, 21 February 2024 Homo sapiens:Overview of proinflammatory and profibrotic mediators (Economize layout) (top)
- 01:58, 21 February 2024 Homo sapiens:Overview of proinflammatory and profibrotic mediators (Color metabolites, standardize font, ecoonomize layout)
- 01:43, 21 February 2024 Homo sapiens:Oxytocin signaling (Identify pathway)
- 01:39, 21 February 2024 Homo sapiens:Oxytocin signaling (Modified description)
- 01:38, 21 February 2024 Homo sapiens:Oxytocin signaling (Ontology Term : 'myometrial cell' added !)
- 01:34, 21 February 2024 Homo sapiens:Vitamin A and carotenoid metabolism (Ontology Term : 'enterocyte' added !)
- 01:31, 21 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Ontology Term : 'neurodegenerative pathway' added !)
- 01:31, 21 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Ontology Term : 'amyotrophic lateral sclerosis pathway' added !)
- 23:11, 20 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Modified description)
- 23:09, 20 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Note relation to Parkinson's disease, per source)
- 23:05, 20 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Note relation to FTD and ALS, per source)
- 22:57, 20 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Note relation to Alzheimer's disease, per source diagram)
- 22:53, 20 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Refine interaction per source; refine metabolite name)
- 21:20, 19 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Refine caption placement)
- 21:19, 19 February 2024 Homo sapiens:Involvement of δ-secretase in neurodegenerative diseases (Fix typo, color metabolites blue, economize)
- 21:08, 19 February 2024 Homo sapiens:Estrogen signaling (Economize layout)
- 17:28, 19 February 2024 Homo sapiens:Estrogen signaling (Untangle interaction, simplify line type, economize layout)
- 17:20, 19 February 2024 Homo sapiens:Estrogen signaling (Upgrade mitochondrion, economize layout)
- 17:12, 19 February 2024 Homo sapiens:Estrogen signaling (Economize layout)
- 16:57, 19 February 2024 Homo sapiens:Estrogen signaling (Straighten remaining lines, economize layout, standardize case)
- 16:14, 19 February 2024 Homo sapiens:Estrogen signaling (Simplify interaction line types)
(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)
